CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathwayJing Yang, Yan‐Qun Xiang, Tingting Zeng et al.|Oncotarget|2015Cited by 62
Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trialGuoying Liu, Yan‐Qun Xiang, Yan-Fang Ye et al.|BMJ|2024Cited by 17
Abstract 2177: Differential expression of stromal cell-related genes between primary nasopharyngeal carcinoma and distant metastasisLiang‐Ru Ke, Xin‐Yuan Guan, Jinna Chen et al.|Cancer Research|2015Cited by 0